A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study

BACKGROUND: Thrombocytopenia is a common adverse event of oxaliplatin-based chemotherapy. Grade 2 or higher oxaliplatin-related thrombocytopenia may result in dose reduction, discontinuation or delay initiation of chemotherapy and may adversely affect the therapeutic efficacy and even overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Yuhong, Cheng, Yiqi, Zhou, Ziling, Li, Zhen, Luo, Yan, Qiu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578303/
https://www.ncbi.nlm.nih.gov/pubmed/37849829
http://dx.doi.org/10.7717/peerj.16230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578303/
https://www.ncbi.nlm.nih.gov/pubmed/37849829
http://dx.doi.org/10.7717/peerj.16230

Ejemplares similares